Citation Impact
Citing Papers
Antiseptics and Disinfectants: Activity, Action, and Resistance
1999 Standout
Suppression of bone resorption by madindoline A, a novel nonpeptide antagonist to gp130
2002 StandoutNobel
Tumour-cell invasion and migration: diversity and escape mechanisms
2003 Standout
Lymphoproliferative disease of granular lymphocytes
1995
Myeloid-derived suppressor cells coming of age
2018 Standout
An immune edited tumour versus a tumour edited immune system: prospects for immune therapy of acute myeloid leukaemia
2006
Identification and expression cloning of a leptin receptor, OB-R
1995 Standout
Colony-stimulating factor-producing tumours: Production of granulocyte colony-stimulating factor and interleukin-6 is secondary to interleukin-1 production
1994 StandoutNobel
The dendritic cell and human cancer vaccines
2000
Active immunization against cancer with dendritic cells: The near future
2001 StandoutNobel
Integrin α5β1: a potent inhibitor of experimental lung metastasis
1998
Hematopoietic Growth Factors
1989
Essential oils: their antibacterial properties and potential applications in foods—a review
2004 Standout
De novo protein design. I. in search of stability and specificity
1999 StandoutNobel
IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin
2004 Standout
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
2005 Standout
Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor
1992
The tolerability and pharmacology of interleukin-6 administered in combination with GM-CSF or G-CSF in the rhesus monkey
1995
Antibiotic proteins of human neutrophils.
1990
The use of dendritic cells in cancer immunotherapy
2003 StandoutNobel
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
1992 StandoutNature
Functions of natural killer cells
2008 Standout
In vitro and in vivo activation of endothelial cells by colony-stimulating factors.
1991
Biology of Natural Killer Cells
1989 Standout
Induction of neutralising antibodies restricts the use of human granulocyte/macrophage colony stimulating factor for vaccine studies in rhesus macaques
2004 StandoutNobel
Designing antimicrobial peptides: form follows function
2011 Standout
Chemotherapy and the war on cancer
2005 Standout
Neutrophilic Leukocyte Granules: From Structure to Function
1993
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer
1991 Standout
Antimicrobial peptides and proteins in mycobacterial therapy: Current status and future prospects
2014
Inflammation and cancer: back to Virchow?
2001 Standout
Peptide therapeutics: current status and future directions
2014 Standout
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization
1999 Standout
Liver damage in patients with colony-stimulating factor-producing tumors
1993 StandoutNobel
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor
1992
T cell receptor gene rearrangements define a monoclonal T cell proliferation in patients with T cell lymphocytosis and cytopenia
1986
The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation
1986 Standout
Induction of Tumor Immunity by Removing CD25+CD4+ T Cells: A Common Basis Between Tumor Immunity and Autoimmunity
1999 StandoutNobel
Activation of JAK2 in Human Vascular Endothelial Cells by Granulocyte-Macrophage Colony-Stimulating Factor
1997
Analysis of G-CSF-producing lung cancer cell lines and non-growth-stimulatory effects of rhG-CSF on lung cancer cells in vitro and in vivo
1992
Three different mRNAs encoding human granulocyte colony-stimulating factor receptor.
1990
Recombinant human interleukin-6 induces a rapid and reversible anemia in cancer patients
1995
The syndrome of T8 hyperlymphocytosis: variation in phenotype and cytotoxic activities of granular cells and evaluation of their role in associated neutropenia
1987
Expansion of natural killer cells but not T cells in human interleukin 2/interleukin 2 receptor (Tac) transgenic mice.
1989 StandoutNobel
Molecular Basis of Bacterial Outer Membrane Permeability Revisited
2003 Standout
Granulated T cell lymphocytosis with neutropenia: malignant or benign chronic lymphoproliferative disorder?
1985
The B7 Family and Cancer Therapy: Costimulation and Coinhibition
2007 StandoutNobel
Cytokines, platelet production and hemostasis
1997
[1] Role of free radicals and catalytic metal ions in human disease: An overview
1990 Standout
Biologic effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma
1995
EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer.
1997 Standout
Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells
2002 StandoutNobel
IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin
2004 Standout
Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells.
1993 Standout
Characterization of the Action of Selected Essential Oil Components on Gram-Negative Bacteria
1998 Standout
Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
1998 Standout
Chimaeric anti‐interleukin 6 monoclonal antibodies in the treatment of advanced multiple myeloma: a phase I dose‐escalating study
1998
Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors
1995
Nonnasal Lymphoma Expressing the Natural Killer Cell Marker CD56: A Clinicopathologic Study of 49 Cases of an Uncommon Aggressive Neoplasm
1997
Combination protocols of cytokine therapy with interleukin-3 and granulocyte-macrophage colony-stimulating factor in a primate model of radiation-induced marrow aplasia
1993
Serum-resistant CpG-STAT3 decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemia
2016
Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130.
1991
The Efficacy of Single-Dose Administration of Thrombopoietin With Coadministration of Either Granulocyte/Macrophage or Granulocyte Colony-Stimulating Factor in Myelosuppressed Rhesus Monkeys
1997
Dose escalation study of recombinant human granulocyte-colony-stimulating factor (KRN8601) in patients with advanced malignancy.
1989
Rearrangements of Genes for the Antigen Receptor on T Cells as Markers of Lineage and Clonality in Human Lymphoid Neoplasms
1985
Purification and characterization of the receptor for murine granulocyte colony-stimulating factor.
1990
Ex vivogeneration of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancer
2015
Premature expression of the macrophage colony-stimulating factor receptor on a multipotential stem cell line does not alter differentiation lineages controlled by stromal cells used for coculture.
1991 StandoutNobel
HOW NEUTROPHILS KILL MICROBES
2005 Standout
The biological significance of lactoferrin in haematology
1984
The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells.
1987
Lymphokine Production in Ty Lymphoproliferative Disorders
1986
Immunotoxins for targeted cancer therapy
1998
Role of T-cell antigens in the cytolytic activities of large granular lymphocytes (LGLs) in patients with LGL lymphocytosis
1988
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Malignant clonal expansion of large granular lymphocytes with a Leu- 11+, Leu-7- surface phenotype: in vitro responsiveness of malignant cells to recombinant human interleukin 2
1986
Leukemia of Large Granular Lymphocytes: Association with Clonal Chromosomal Abnormalities and Autoimmune Neutropenia, Thrombocytopenia, and Hemolytic Anemia
1985
Interleukin-5, eosinophils, and disease
1992 Standout
Stimulation of the Na+/H+ exchanger in human endothelial cells activated by granulocyte- and granulocyte-macrophage-colony-stimulating factor
1989
Thermodynamics and Structural Studies of the Interaction of Polymyxin B with Deep Rough Mutant Lipopolysaccharides
1999 StandoutNobel
NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate Cytokines
1999 Standout
Agents that increase the permeability of the outer membrane
1992 Standout
Leukemia cell–targeted STAT3 silencing and TLR9 triggering generate systemic antitumor immunity
2013
Residue 21 of human granulocyte-macrophage colony-stimulating factor is critical for biological activity and for high but not low affinity binding.
1992
Interleukin-2: Inception, Impact, and Implications
1988 StandoutScience
Works of EF Winton being referenced
Cytokine upregulation of the antigen presenting function of acute myeloid leukemia cells
2000
Spontaneous regression of a monoclonal proliferation of large granular lymphocytes associated with reversal of anemia and neutropenia
1986
Various human hematopoietic growth factors (interleukin-3, GM-CSF, G- CSF) stimulate clonal growth of nonhematopoietic tumor cells [see comments]
1989
The ontogeny of a 57-Kd cationic antimicrobial protein of human polymorphonuclear leukocytes: localization to a novel granule population
1990
The ontogeny of a 57-Kd cationic antimicrobial protein of human polymorphonuclear leukocytes: localization to a novel granule population
1990
Leukemia of non-T lineage natural killer cells
1988
Differential effects of sequential, simultaneous, and single agent interleukin-3 and granulocyte-macrophage colony-stimulating factor on megakaryocyte maturation and platelet response in primates
1992
Heterogeneity of large granular lymphocyte proliferations: delineation of two major subtypes
1986
Differential effects of sequential, simultaneous, and single agent interleukin-3 and granulocyte-macrophage colony-stimulating factor on megakaryocyte maturation and platelet response in primates
1992
Effects of human interleukin-6 on megakaryocyte development and thrombocytopoiesis in primates
1991
In vitro studies of lactoferrin and murine granulopoiesis
1981
A morphologic and immunologic study of the large granular lymphocyte in neutropenia with T lymphocytosis
1984